4Moses JW,Stone GW,Nikolsky E,et al.Drug-eluting stents in the treat-ment of intermediate lesions:pooled analysis from four randomized trials(J).J Am Coll Cardiol,2006;47(11):2164-71.
6Cannon CP,Weintraub WS,Demopoulos LA,et al.Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoproteinⅡb/Ⅲa inhibitor tirofiban(J).N Engl J Med,2001;344(25):1879-87.
7Sahara M,Kirigaya H,Oikawa Y,et al.Soft plaque detected on intravas-cular ultrasound is the strongest predictor of instent restenosis an intravas-cular ultrasound study(J).Eur Heart J,2004;25(22):2026-33.
1Walker DB, Jacobson TA. Intiating statins in the elderly: the evolving challenge . Curr Opin Endocrinol Diabetes Obes, 2008, 15 : 182-187.
2Mangoni AA, Jackson SH. The implication of growing evidence base for drug use elderly patients. Part I . Statins for primary and secondary cardiovascular prevention. Br J Clin Pharmacol ,2006, 61:494-501.
3The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med, 1998,339 : 1349-1357.
4MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high risk individuals : a randomized placebocontrolled trial. Lancet,2002,360 : 7 -22.
5Wenger N, Lewis S, Herrington D, et al. Outcomes of using highor-lowdose atorvastatin in patients 65 years of age or older with stable coronary heart disease. Ann Intern Med, 2007,147:1-9.
6Koren M, Mendes R, Luo D. Efficacy and safety of high dose atorvastatin therapy in CHD patients ≥ 65 years of age in the Aggressive Lipid Lowering Ahates New Cardiac Events (ALLIANCE) study [ abstract ]. Circulation, 2005, 112 ( Suppl S) : U726.
7Deedwania P, Stone PH, Merz NB, et al. Effects of intensive versus moderate lipid-lowering therapy on myocardial ischemia in older patients with coronary heart disease: results of the study assessing goals in the elderly (SAGE). Circulation, 2007,115 : 700-707.
8Afilalo J, Duque G, Steele R, et al. Statin for secondary prevention in elderly patients. A Hierarchial Bayesian Meta- Analysis. J Am Coil Cardiol,2008,51:37-45.
9Allen MCA, Muhlestein JB, Home BD, et al. Effectiveness of statin therapy in adults with coronary heart disease. Arch Intern Med ,2004,164 : 1427-1436.
10Alter DA, Manuel DG, Gunraj N, et al. Age, risk-benefit tradeoffs, and the projected effects of evidence-based therapies. Am J Med ,2004,116:540-545.
